Evidence map›Paper›PMID 39519258›Full record

ArticleInternational journal of molecular sciences2024

Association of Genetic Variants at the

Lidia Ciszak, Agata Kosmaczewska, Edyta Pawlak, Irena Frydecka, Aleksandra Szteblich, Dariusz Wołowiec

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lidia CiszakDepartment of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.ORCID 0000-0002-5135-6336
Agata KosmaczewskaDepartment of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.ORCID 0000-0002-3805-9476
Edyta PawlakDepartment of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.ORCID 0000-0002-0386-7940
Irena FrydeckaDepartment of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Aleksandra SzteblichDepartment of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Dariusz WołowiecClinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Funding

Wroclaw Medical University ST.C140.16.076
6 · The paper itself

Abstract

Beyond the essential role of p27

Indexed as

Cyclin D2Cyclin-Dependent Kinase Inhibitor p27Genetic Predisposition to DiseaseLeukemia, Lymphocytic, Chronic, B-CellPolymorphism, Single NucleotideAdultAgedB-LymphocytesFemaleGenotypeHumansMaleMiddle AgedCCND2 protein, humanCDKN1B protein, humanCyclin D2Cyclin-Dependent Kinase Inhibitor p27CCND2 gene polymorphismCDKN1B gene polymorphismchronic lymphocytic leukemia (CLL)cyclin D2p27Kip1 protein

Identifiers

PMID39519258
PMCPMC11546115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.